Low-grade inflammation in persons with recently diagnosed type 2 diabetes: The role of abdominal adiposity and putative mediators.
body composition
cohort study
insulin resistance
observational study
population study
type 2 diabetes
Journal
Diabetes, obesity & metabolism
ISSN: 1463-1326
Titre abrégé: Diabetes Obes Metab
Pays: England
ID NLM: 100883645
Informations de publication
Date de publication:
11 Mar 2024
11 Mar 2024
Historique:
revised:
29
01
2024
received:
24
11
2023
accepted:
07
02
2024
medline:
11
3
2024
pubmed:
11
3
2024
entrez:
11
3
2024
Statut:
aheadofprint
Résumé
To determine the magnitude of the association between abdominal adiposity and low-grade inflammation in persons with recently diagnosed type 2 diabetes (T2D) and to determine to what extent this association is mediated by low physical activity level, hyperinsulinaemia, hyperglycaemia, dyslipidaemia, hypertension, and comorbidities. We measured waist circumference, clinical characteristics, and inflammatory markers i.e. tumour necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and high-sensitivity C-reactive protein (hsCRP), in >9000 persons with recently diagnosed T2D. We applied multiple mediation analysis using structural equation modelling, with adjustment for age and sex. Waist circumference as a proxy for abdominal adiposity was positively associated with all inflammatory markers. Hence, a one-standard deviation (SD) increase in waist circumference (SD = 15 cm) was associated with a 22%, 35%, and 46% SD increase in TNF-α (SD = 1.5 pg/mL), IL-6 (SD = 4.4 pg/mL), and hsCRP (SD = 6.9 mg/L), respectively. The level of hyperinsulinaemia assessed by fasting C-peptide was quantitatively the most important mediator, accounting for 9%-25% of the association between abdominal adiposity and low-grade inflammation, followed by low physical activity (5%-7%) and high triglyceride levels (2%-6%). Although mediation of adiposity-induced inflammation by greater comorbidity and higher glycated haemoglobin levels reached statistical significance, their impact was minor (1%-2%). In persons with recently diagnosed T2D, there was a clear association between abdominal adiposity and low-grade inflammation. A considerable part (20%-40%) of this association was mediated by other factors, with hyperinsulinaemia as a potentially important driver of adiposity-induced inflammation in T2D.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Danish Agency for Science and Higher Education
ID : 09-067009
Organisme : Danish Agency for Science and Higher Education
ID : 09-075724
Organisme : Sundhedsstyrelsen
Organisme : Diabetesforeningen
Organisme : Region Syddanmark
Organisme : Novo Nordisk Fonden
ID : NNF17SA0030364
Organisme : Novo Nordisk Fonden
ID : NNF17SA0030962-2
Organisme : Novo Nordisk Fonden
ID : NNF20O0063292
Informations de copyright
© 2024 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd.
Références
Festa A, D'Agostino R Jr, Williams K, et al. The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord. 2001;25(10):1407-1415. doi:10.1038/sj.ijo.0801792
Park HS, Park JY, Yu R. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res Clin Pract. 2005;69(1):29-35. doi:10.1016/j.diabres.2004.11.007
Brinkley TE, Hsu FC, Beavers KM, et al. Total and abdominal adiposity are associated with inflammation in older adults using a factor analysis approach. J Gerontol A Biol Sci Med Sci. 2012;67(10):1099-1106. doi:10.1093/gerona/gls077
Ridker PM, Bhatt DL, Pradhan AD, Glynn RJ, MacFadyen JG, Nissen SE. Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials. Lancet. 2023;401:1293-1301. doi:10.1016/S0140-6736(23)00215-5
Ridker PM, MacFadyen JG, Everett BM, Libby P, Thuren T, Glynn RJ. Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial. Lancet. 2018;391(10118):319-328. doi:10.1016/s0140-6736(17)32814-3
Okdahl T, Wegeberg A-M, Pociot F, Brock B, Størling J, Brock C. Low-grade inflammation in type 2 diabetes: a cross-sectional study from a Danish diabetes outpatient clinic. BMJ Open. 2022;12(12):e062188. doi:10.1136/bmjopen-2022-062188
van Greevenbroek MM, Schalkwijk CG, Stehouwer CD. Obesity-associated low-grade inflammation in type 2 diabetes mellitus: causes and consequences. Neth J Med. 2013;71(4):174-187.
Pedersen DJ, Guilherme A, Danai LV, et al. A major role of insulin in promoting obesity-associated adipose tissue inflammation. Mol Metab. 2015;4(7):507-518. doi:10.1016/j.molmet.2015.04.003
Shimobayashi M, Albert V, Woelnerhanssen B, et al. Insulin resistance causes inflammation in adipose tissue. J Clin Invest. 2018;128(4):1538-1550. doi:10.1172/jci96139
Hamer M, Sabia S, Batty GD, et al. Physical activity and inflammatory markers over 10 years. Circulation. 2012;126(8):928-933. doi:10.1161/CIRCULATIONAHA.112.103879
Vandercappellen EJ, Koster A, Savelberg HHCM, et al. Sedentary behaviour and physical activity are associated with biomarkers of endothelial dysfunction and low-grade inflammation-relevance for (pre)diabetes: the Maastricht study. Diabetologia. 2022;65(5):777-789. doi:10.1007/s00125-022-05651-3
Solak Y, Afsar B, Vaziri ND, et al. Hypertension as an autoimmune and inflammatory disease. Hypertens Res. 2016;39(8):567-573. doi:10.1038/hr.2016.35
Van't Klooster CC, Ridker PM, Hjortnaes J, et al. The relation between systemic inflammation and incident cancer in patients with stable cardiovascular disease: a cohort study. Eur Heart J. 2019;40(48):3901-3909. doi:10.1093/eurheartj/ehz587
Hong N, Lin Y, Ye Z, et al. The relationship between dyslipidemia and inflammation among adults in east coast China: a cross-sectional study. Front Immunol. 2022;13:937201. doi:10.3389/fimmu.2022.937201
Vasbinder A, Anderson E, Shadid H, et al. Inflammation, hyperglycemia, and adverse outcomes in individuals with diabetes mellitus hospitalized for COVID-19. Diabetes Care. 2022;45(3):692-700. doi:10.2337/dc21-2102
Nielsen JS, Thomsen RW, Steffensen C, Christiansen JS. The Danish Centre for Strategic Research in type 2 diabetes (DD2) study: implementation of a nationwide patient enrollment system. Clin Epidemiol. 2012;4(Suppl 1):27-36. doi:10.2147/CLEP.S30838
Han TS, Sattar N, Lean M. ABC of obesity. Assessment of obesity and its clinical implications. BMJ. 2006;333(7570):695-698. doi:10.1136/bmj.333.7570.695
Holt CB, Østergaard JA, Thiel S, et al. Circulating lectin pathway proteins do not predict short-term cardiac outcomes after myocardial infarction. Clin Exp Immunol. 2019;198(1):94-100. doi:10.1111/cei.13315
Gedebjerg A, Thomsen RW, Kjaergaard AD, et al. Mannose-binding lectin and risk of infections in type 2 diabetes: a Danish cohort study. J Diabetes Complications. 2021;35(5):107873. doi:10.1016/j.jdiacomp.2021.107873
Saltin B, Grimby G. Physiological analysis of middle-aged and old former athletes. Comparison with still active athletes of the same ages. Circulation. 1968;38(6):1104-1115. doi:10.1161/01.cir.38.6.1104
Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care. 1998;21(12):2191-2192. doi:10.2337/diacare.21.12.2191
Schmidt M, Schmidt SA, Sandegaard JL, Ehrenstein V, Pedersen L, Sørensen HT. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449-490. doi:10.2147/clep.S91125
Khera AV, Chaffin M, Aragam KG, et al. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat Genet. 2018;50(9):1219-1224. doi:10.1038/s41588-018-0183-z
Stidsen JV, Henriksen JE, Olsen MH, et al. Pathophysiology-based phenotyping in type 2 diabetes: a clinical classification tool. Diabetes Metab Res Rev. 2018;34(5):e3005. doi:10.1002/dmrr.3005
Zhao X, Lynch J, Chen Q. Reconsidering baron and Kenny: myths and truths about mediation analysis. J Consum Res. 2010;37(2):197-206. doi:10.1086/651257
Mileti E, Kwok KHM, Andersson DP, et al. Human white adipose tissue displays selective insulin resistance in the obese state. Diabetes. 2021;70(7):1486-1497. doi:10.2337/db21-0001
Püschel GP, Klauder J, Henkel J. Macrophages, low-grade inflammation, insulin resistance and hyperinsulinemia: a mutual ambiguous relationship in the development of metabolic diseases. J Clin Med. 2022;11(15):4358.
Wright AK, Suarez-Ortegon MF, Read SH, et al. Risk factor control and cardiovascular event risk in people with type 2 diabetes in primary and secondary prevention settings. Circulation. 2020;142(20):1925-1936. doi:10.1161/CIRCULATIONAHA.120.046783
Burini RC, Anderson E, Durstine JL, Carson JA. Inflammation, physical activity, and chronic disease: an evolutionary perspective. Sports Med Health Sci. 2020;2(1):1-6. doi:10.1016/j.smhs.2020.03.004
Fischer CP, Berntsen A, Perstrup LB, Eskildsen P, Pedersen BK. Plasma levels of interleukin-6 and C-reactive protein are associated with physical inactivity independent of obesity. Scand J Med Sci Sports. 2007;17(5):580-587. doi:10.1111/j.1600-0838.2006.00602.x
Chen X, Sun X, Wang C, He H. Effects of exercise on inflammatory cytokines in patients with type 2 diabetes: a meta-analysis of randomized controlled trials. Oxid Med Cell Longev. 2020;2020:6660557. doi:10.1155/2020/6660557
Balducci S, Zanuso S, Nicolucci A, et al. Anti-inflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight loss. Nutr Metab Cardiovasc Dis. 2010;20(8):608-617. doi:10.1016/j.numecd.2009.04.015
Cook JR, Hawkins MA, Pajvani UB. Liver insulinization as a driver of triglyceride dysmetabolism. Nat Metab. 2023;5(7):1101-1110. doi:10.1038/s42255-023-00843-6
Subramanian S, Chait A. Hypertriglyceridemia secondary to obesity and diabetes. Biochim Biophys Acta Mol Cell Biol Lipids. 2012;1821(5):819-825. doi:10.1016/j.bbalip.2011.10.003
März W, Scharnagl H, Winkler K, et al. Low-density lipoprotein triglycerides associated with low-grade systemic inflammation, adhesion molecules, and angiographic coronary artery disease: the Ludwigshafen risk and cardiovascular health study. Circulation. 2004;110(19):3068-3074. doi:10.1161/01.Cir.0000146898.06923.80